| Financial Year |
March 31 2023 |
| Monetary Funds |
296,978,911.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,200,000.00 |
| Accounts Receivable |
2,487,681,504.41 |
| Advances to Suppliers |
336,761,025.16 |
| Other Receivables |
79,680,496.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,417,949.91 |
| Inventories |
16,400,761.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,000,000.00 |
| Other Current Assets |
8,623,074.62 |
| Total Current Assets |
3,300,045,008.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,653,079.53 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,913,192.78 |
| Under-construction Projects |
164,978,032.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,061,376.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,605,318.76 |
| Deferred Income Tax Assets |
17,661,994.22 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,409,084,617.91 |
| Total Assets |
4,709,129,626.02 |
| Short-Term Loans |
560,294,571.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
280,000,000.00 |
| Accounts Payable |
709,908,543.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,470,782.78 |
| Taxes Payable |
53,937,314.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,204,513.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,568,084.44 |
| Other Current Liabilities |
51,588,630.30 |
| Sub-Total of Current Liabilities |
1,753,782,945.08 |
| Long-term Loans |
114,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
72,945,330.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
214,261,109.74 |
| Total Liabilities |
1,968,044,054.82 |
| Paid-In Capital(Or Share Stock) |
101,407,289.00 |
| Capital Surplus |
1,088,811,563.15 |
| Surplus Reserve |
75,205,508.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,454,374,951.91 |
| Minority Stockholder's Interest |
21,286,258.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,719,799,312.65 |
| Owner's Equity（Stockholder's Equity） |
2,741,085,571.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,709,129,626.02 |
